The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Influence of the Novel Inotropic Agent Levosimendan on Isometric Tension and Calcium Cycling in Failing Human Myocardium
Abstract
Background —Levosimendan was shown to increase calcium sensitivity by a novel mechanism and to inhibit phosphodiesterase III activity in animal myocardium. Methods and Results —We investigated the influence of levosimendan on isometric contractions and calcium transients (aequorin method) in muscle strips from human hearts with end-stage failing dilated or ischemic cardiomyopathy (n=27). Data were compared with the effects of the phosphodiesterase inhibitor milrinone (n=9). The average maximum increase in twitch tension was 47±14% (range, 6% to 150%) at a levosimendan concentration of 0.8±0.3 μmol/L ( P <0.01). This was associated with significant increases in maximum rates of tension rise and fall and decreases in times to peak tension, to 50% relaxation, and to 95% relaxation. In aequorin-loaded muscles, levosimendan 10 −6 mol/L increased average tension by 50% ( P <0.02), associated with a nonsignificant increase in aequorin light (16%). With milrinone 10 −5 mol/L, average tension increased by 58% and aequorin light by 49% ( P <0.05). In those muscle strips with pronounced inotropic effects (>50% increase in tension), there was a comparable and pronounced increase in aequorin light with both agents. However, in muscle strips with weak inotropic responses (<50% increase in tension), the increase in light was significantly higher with milrinone than with levosimendan. Conclusions —Levosimendan has inotropic and lusitropic actions in failing human myocardium. Comparison with the phosphodiesterase inhibitor milrinone indicates that in case of pronounced inotropic stimulation, the modes of action of the two agents may be similar (phosphodiesterase inhibition), whereas small inotropic effects of levosimendan may result predominantly from calcium sensitization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
Feldman, A. M., Bristow, M. R., Parmley, W. W., Carson, P. E., Pepine, C. J., Gilbert, E. M., Strobeck, J. E., Hendrix, G. H., Powers, E. R., Bain, R. P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290301 · Cited by 475
Pieske, B., Kretschmann, B., Meyer, M., Holubarsch, C., Weirich, J., Posival, H., Minami, K., Just, H., & Hasenfuss, G. (1995) · Circulation · doi:10.1161/01.cir.92.5.1169 · Cited by 377
Self-citationUretsky, B. F., Jessup, M., Konstam, M. A., Dec, G. W., Leier, C. V., Benotti, J., Murali, S., Herrmann, H. C., & Sandberg, J. A. (1990) · Circulation · doi:10.1161/01.cir.82.3.774 · Cited by 321
Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
Haikala, H. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90009-8 · Cited by 304
Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime.
Mulieri, L. A., Hasenfuss, G., Ittleman, F., Blanchard, E. M., & Alpert, N. R. (1989) · Circulation Research · doi:10.1161/01.res.65.5.1441 · Cited by 276
Self-citationPollesello, P., Ovaska, M., Kaivola, J., Tilgmann, C., Lundström, K., Kalkkinen, N., Ulmanen, I., Nissinen, E., & Taskinen, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61945-9 · Cited by 232
Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation
Haikala, H., Nissinen, E., Etemadzadeh, E., Levijoki, J. M., & Lindén, I. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199505000-00016 · Cited by 224
Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy.
Hasenfuss, G., Mulieri, L. A., Leavitt, B. J., Allen, P. D., Haeberle, J. R., & Alpert, N. R. (1992) · Circulation Research · doi:10.1161/01.res.70.6.1225 · Cited by 220
Self-citationStereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments.
Solaro, R. J., Gambassi, G., Warshaw, D. M., Keller, M. R., Spurgeon, H. A., Beier, N., & Lakatta, E. G. (1993) · Circulation Research · doi:10.1161/01.res.73.6.981 · Cited by 162
Böhm, M., Morano, I. L., Pieske, B. M., Rüegg, J. C., Wankerl, M., Zimmermann, R., & Erdmann, E. (1991) · Circulation Research · doi:10.1161/01.res.68.3.689 · Cited by 138
Self-citationKatz, A. M. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80387-8 · Cited by 125
Haikala, H., Levijoki, J. M., & Lindén, I.-B. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91371-8 · Cited by 69
Calcium-sensitizing inotropic agents in the treatment of heart failure: A critical view
Hajjar, R. J., & Gwathmey, J. K. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00143520 · Cited by 46
Kihara, Y., & Morgan, J. P. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92011-1 · Cited by 46
Hasenfuss, G., Mulieri, L. A., Leavitt, B. J., & Alpert, N. R. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1165 · Cited by 37
Self-citation
Cited by
Follath, F., Cleland, J., Just, H., Papp, J., Scholz, H., Peuhkurinen, K., Harjola, V., Mitrovic, V, Abdalla, M., Sandell, E.-P., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09455-2 · Cited by 1,185
Self-citationInotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease
Overgaard, C. B., & Džavík, V. (2008) · Circulation · doi:10.1161/circulationaha.107.728840 · Cited by 516
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
Slawsky, M. T., Colucci, W. S., Gottlieb, S. S., Greenberg, B. H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H., Loh, E., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2222 · Cited by 478
Loss of Metabolic Flexibility in the Failing Heart
Karwi, Q. G., Uddin, G. M., Ho, K. L., & Lopaschuk, G. D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00068 · Cited by 442
Levosimendan: Molecular mechanisms and clinical implications
Papp, Z., Édes, I., Fruhwald, S., De Hert, S. G., Salmenperä, M., Leppikangas, H., Mebazaa, A., Landoni, G., Grossini, E., Caimmi, P., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.022 · Cited by 319
Metadata
- Authors
- Hasenfuss, G., Pieske, B., Castell, M., Kretschmann, B., Maier, L. S., & Just, H.
- Venue
- Circulation
- Published
- 1998-11-17
- Volume
- 98
- Issue
- 20
- Pages
- 2141-2147
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2017397568
- Cited by
- 302
- References
- 20
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.